Apheris delivers enterprise-grade AI applications for drug discovery, designed for pharma companies to run and customize securely within their own IT environments. By keeping all data local, organizations maintain full sovereignty over IP-sensitive assets. These local deployments also serve as the foundation for Apheris-hosted federated data networks, where pharma companies collaboratively train and benchmark models on proprietary datasets to unlock more robust and generalizable models for drug discovery.
| Website | https://www.apheris.com/ |
| Revenue | $7.4 million |
| Employees | 61 (42 on RocketReach) |
| Founded | 2019 |
| Phone | +49 491 7657864816 |
| Industry | Biotechnology Research |
| Keywords | Secure Data Access, Data Analytics Security, Secure Data Sharing, Ai Data Security, Private Data Sharing, Secure Data Platform, Data Access Control, Data Access Management, Machine Learning Data, Data Protection, Data Privacy |
| Competitors | Benchling, Twist Bioscience, Synthego Corporation, Cryoport, Zymergen, Inc., DNA Script, Synthace, Strateos, Primordial Genetics, Sestina Bio, LLC. +37 more (view full list) |
Looking for a particular Apheris employee's phone or email?
The Apheris annual revenue was $7.4 million in 2026.
Robin Roehm is the CEO and Co-Founder of Apheris.
42 people are employed at Apheris.
Apheris is based in Berlin, Berlin.